How does GALN.F's PE Ratio compare to its peers?

GALN.F is expensive based on its Price-To-Earnings Ratio (21.7x) compared to the peer average (20.4x).

How does GALN.F's PE Ratio compare vs other companies in the US Healthcare Industry?

GALN.F is good value based on its Price-To-Earnings Ratio (21.7x) compared to the US Healthcare industry average (23.3x).

What is GALN.F's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

Insufficient data to calculate GALN.F's Price-To-Earnings Fair Ratio for valuation analysis.

What is the Fair Price of GALN.F when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

GALN.F ($75.25) is trading below our estimate of [[fair value]] ($96.14)

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Insufficient data to show price forecast.

GALN.F Stock Overview

Operates as a healthcare service provider in Switzerland and internationally. More details

GALN.F fundamental analysis
Snowflake Score
Valuation	3/6
Future Growth	1/6
Past Performance	2/6
Financial Health	5/6
Dividends	3/6

Rewards

Trading at 21.7% below our estimate of its fair value

Earnings are forecast to grow 3.96% per year

Risk Analysis

Shares are highly illiquid

Unstable dividend track record

My Notes

Capture your thoughts, links and company narrative

Galenica AG Competitors

Patterson Companies

NasdaqGS:PDCO

US$2.7b

Henry Schein

NasdaqGS:HSIC

US$8.7b

Cardinal Health

NYSE:CAH

US$28.8b

Cencora

NYSE:COR

US$44.0b

Price History & Performance

Summary of share price highs, lows and changes for Galenica
Historical stock prices
Current Share Price	CHF 75.25
52 Week High	CHF 77.80
52 Week Low	CHF 75.25
Beta	0.19
1 Month Change	0%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-3.28%

Recent updates

Shareholder Returns

	GALN.F	US Healthcare	US Market
7D	0%	3.3%	2.8%
1Y	n/a	-9.1%	24.6%

Return vs Industry: Insufficient data to determine how GALN.F performed against the US Healthcare industry.

Return vs Market: Insufficient data to determine how GALN.F performed against the US Market.

Price Volatility

Is GALN.F's price volatile compared to industry and market?
GALN.F volatility
GALN.F Average Weekly Movement	n/a
Healthcare Industry Average Movement	7.7%
Market Average Movement	6.3%
10% most volatile stocks in US Market	17.4%
10% least volatile stocks in US Market	3.1%

Stable Share Price: GALN.F has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine GALN.F's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1927	5,517	Marc Werner	www.galenica.com

Galenica AG operates as a healthcare service provider in Switzerland and internationally. It operates through two segments, Products & Care, and Logistics & IT. The Products & Care segment operates 520 pharmacies, including 368 owned pharmacies and 152 partner pharmacies under the Amavita, Sun Store, and Coop Vitality brands.

Galenica AG Fundamentals Summary

How do Galenica's earnings and revenue compare to its market cap?
GALN.F fundamental statistics
Market cap	US$4.03b
Earnings (TTM)	US$185.30m
Revenue (TTM)	US$4.27b

21.7x

P/E Ratio

0.9x

P/S Ratio

Is GALN.F overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
GALN.F income statement (TTM)
Revenue	CHF 3.94b
Cost of Revenue	CHF 3.50b
Gross Profit	CHF 445.25m
Other Expenses	CHF 273.96m
Earnings	CHF 171.29m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

Mar 07, 2023

Earnings per share (EPS)	3.45
Gross Margin	11.29%
Net Profit Margin	4.34%
Debt/Equity Ratio	36.5%

How did GALN.F perform over the long term?

See historical performance and comparison

Dividends

2.8%

Current Dividend Yield

61%

Payout Ratio

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2023/02/20 16:33
End of Day Share Price	2022/11/23 00:00
Earnings	2022/06/30
Annual Earnings	2021/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Galenica AG is covered by 12 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Bruno Bulic	Baader Helvea Equity Research
Volker Bosse	Baader Helvea Equity Research
Alexander Berglund	BofA Global Research